From Biomarkers to Better Outcomes: Precision Medicine in Modern Internal Medicine
Keywords:
Precision Medicine, Internal Medicine, Biomarker, artificial intelligence, Pharmacogenetics, Multi-OmicsAbstract
Internal medicine has traditionally focused on population-based approaches, utilizing diagnostic algorithms and treatment thresholds designed for the "average" patient. While beneficial, this one-size-fits-all model often leads to treatment failures. Precision medicine addresses this limitation by tailoring medical care to an individual's unique molecular, genetic, and clinical profile. Driven by advancements in multi-omics platforms, novel biomarkers, artificial intelligence (AI), and pharmacogenomics, precision medicine is transforming modern internal medicine from oncology into routine clinical practice. However, integrating these tools presents significant challenges, including high costs, lack of assay standardization, and the need for enhanced clinician literacy. Addressing these hurdles and ensuring equitable access are essential for translating biomarkers into better patient outcomes.References
Zamperla MG, Barbi V, Negri S, Atlante S, Gaetano C. Omics medicine: what the clinicians should know. Eur J Intern Med. 2026;148:106759. doi:10.1016/j.ejim.2026.106759
Santacroce G, Bello AL, Iacucci M, Sabatino AD. Integrating multi-omics and artificial intelligence in internal medicine: opportunities for precision care. Eur J Intern Med. 2026;148:106872. doi:10.1016/j.ejim.2026.106872
Camps J, Fort-Gallifa I, Gabaldó-Barrios X. The transformative role of molecular, cellular, and blood biomarkers in precision medicine. Biomolecules. 2025;15(12):1680. doi:10.3390/biom15121680
Entuc AM, Bogdan M, Boboc IKS, et al. Selected emerging biomarkers in type 2 diabetes mellitus: clinical insights and implications for precision care. Medicina. 2026;62(1):152. doi:10.3390/medicina62010152
Dopierała M, Nitz N, Król O, Wasicka-Przewoźna K, Schwermer K, Pawlaczyk K. New and emerging biomarkers in chronic kidney disease. Biomedicines. 2025;13(6):1423. doi:10.3390/biomedicines13061423
Fujita W, Sakamoto A, Sato E, Kaneko T, Kagiyama N. Transformative impact of artificial intelligence on internal medicine: current applications, challenges, and future horizons for urban health. Juntendo Med J. 2025;71(6):389-98. doi:10.14789/ejmj.JMJ25-0019-R
Marques-Garcia F, Martinez-Bravo C. A review of pharmacogenomics in the individualization of pharmacological treatment: present and future. J Lab Precis Med. 2026;11(6): 1-16. doi:10.21037/jlpm-25-9
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Laurentius Aswin Pramono
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
